Clinical trial reporting: Amgen shines while Astellas languishes
This article was originally published in Scrip
Executive Summary
Amgen's commitment to clinical trials transparency shone out in a report published by Citeline, Reporting Bias in Clinical Trials: What's the current status?, while Astellas's reporting habits fell well short of the industry average. Overall, the report showed that the state of clinical trial reporting may not be as dire as people have been led to believe.